Swedish Medical Center-Ballard Campus — Seattle, Washington

Swedish Medical Center-Ballard Campus is a clinical research site located in Seattle, Washington, United States 98107.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

Swedish Medical Center-Ballard Campus has participated in 215 clinical trials with 144 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Seattle

Browse all research sites in Washington · View every site in Seattle

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Swedish Medical Center-Ballard Campus?

Swedish Medical Center-Ballard Campus has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Swedish Medical Center-Ballard Campus conducted?

Swedish Medical Center-Ballard Campus has 215 clinical trials on record, with 144 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Swedish Medical Center-Ballard Campus accredited by Crixeo Clinical Trials?

Swedish Medical Center-Ballard Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Swedish Medical Center-Ballard Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.